In 2017, Sun et al. again screened 62 known cancer-susceptibility genes among 8085 unselected Chinese patients with breast cancer, and they found 285 BRCA2, 146 BRCA1, 56 PALB2, 38 TP53, and 30 RECQ1 mutated patients. This evidence concerns the gene RECQL and cancer.